Navigation Links
Telcyta in Medical News

Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer

PALO ALTO, Calif., May 31 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) today announced presentation at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, of results from the ASSIST-5 Phase 3 randomized, multinational study of TELCYTA(...

Telik Announces Preclinical Presentations at AACR Annual Meeting

...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Fourth Quarter and 2008 Year End Financial Results and 2009 Financial Guidance

.... Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. St...

Telik Announces Year-End Financial Release, Conference Call and Webcast

...overy technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...
Telcyta in Medical Technology

Telik Announces Telcyta Clinical and Preclinical Presentations at AACR Meeting

PALO ALTO, Calif., April 09, 2007 /PRNewswire-FirstCall/ -- Telik, Inc. announced that updated clinical data from its multicenter Phase 2 trial of the triplet combination of TELCYTA(R) (canfosfamide HCl, TLK286), carboplatin and paclitaxel will be presented at the 98th annual meeting of the Americ...

Telik Reports Positive Data Demonstrating Synergy in Combination and Highly Statistically Significant Effect of Telcyta as Maintenance Therapy in First-Line Non-Small Cell Lung Cancer

PALO ALTO, Calif., April 17, 2007 /PRNewswire-FirstCall/ -- Telik, Inc. announced the presentation today of results from a Phase 2 clinical trial of the triplet combination of TELCYTA(R) (canfosfamide HCl, TLK286), carboplatin and paclitaxel in the first-line treatment of advanced non-small cell l...

Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome

...very technology, TRAP((R)), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Presentation at ASCO Annual Meeting

...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies

...ik's results to differ materially from those indicated by these forward-looking statements, including, among others, if clinical trials of TELINTRA or telcyta are delayed or unsuccessful, Telik's business would suffer, if Telik's competitors develop and market products that are more effective than its produc...
Telcyta in Biological Technology

FDA Removes Partial Hold on TELCYTA Clinical Development

PALO ALTO, Calif., Oct. 15 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) announced that the U.S. Food and Drug Administration (FDA) has removed the partial hold on TELCYTA(R) (canfosfamide HCl, TLK286) clinical trials. This action follows a complete review of TELCYTA data by the agenc...

Telik Announces Second Quarter 2009 Financial Results

...king statements, including, among others, if clinical trials of TELINTRA or telcyta are delayed or unsuccessful, Telik's business would suffer, if Telik's comp...ts contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Reports Preclinical Results at AACR Annual Meeting

...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Implements Reorganization to Focus Resources Toward Drug Development Pipeline

...iodic filings with the SEC. The Company does not undertake any obligation to update forward-looking statements. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Financial Results for 2008 Third Quarter

...2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. Statements of Op...

Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer

...ts from an interrupted Phase 3 randomized study of telcyta (canfosfamide HCL) in combination with pegylated l...gression-free survival (PFS) was 5.6 months on the telcyta plus PLD arm compared to 3.7 months on the PLD con...um resistant disease, including 40 patients on the telcyta plus PLD arm and 35 patients on the PLD control ar...

Telik Announces 2008 Third Quarter Financial Release, Conference Call and Webcast

...g discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Financial Results For 2008 Second Quarter

...2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. Statements of O...

Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast

...g discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces First Quarter 2008 Financial Results

...oking" statements, including statements regarding the future development of telcyta and TELINTRA. These forward-looking statements are based upon Telik's curre... forward-looking statements, including, among others, if clinical trials of telcyta or TELINTRA are delayed or unsuccessful, Telik's business would suffer, if ...
Other Tags
(Date:10/1/2014)... October 01, 2014 NoteSwift Inc., announced ... versions 10.0, 12.1 and 13.0. NoteSwift is the bridge ... commands to navigate and document clinical information at the ... spends creating a patient note by more than half ... the major pain points providers state impedes EHR use ...
(Date:10/1/2014)... October 01, 2014 Scientists at the ... drugs that target immune system proteins has the power ... just posted details of the new study on their ... , Researchers in the UWA School of Pathology ... drugs to mice with mesothelioma with promising results. ...
(Date:10/1/2014)... Bahir Dar, Ethiopia, at the occasion of the ... some 150 African and international leishmaniasis experts, results ... and efficacy monitoring plan, carried out by ... Uganda, and Ethiopia, were presented to key decision ... treatment of kala-azar with the combination of Sodium ...
(Date:10/1/2014)... October is national Breast Cancer Awareness Month—an ... while raising money for breast cancer research. Pelican Water ... in the effort to find a cure. ... of having access to clean, healthy water. Research has ... certain forms of cancer. , The Problem of ...
(Date:10/1/2014)... Dr. Saj Jivraj, one of the world’s ... to Chennai, India, tomorrow to speak at the Indian ... , Dr. Jivraj is founder of the Anacapa Dental ... one of the world’s foremost prosthodontists, meaning he is ... speaking to the Indian Society of Oral Implantologists about ...
Breaking Medicine News(10 mins):Health News:NoteSwift Joins Allscripts Developer Program 2Health News:NoteSwift Joins Allscripts Developer Program 3Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Results of large-scale roll out of combination treatment for kala-azar in Eastern Africa 2Health News:Pelican Water Supports Breast Cancer Awareness Month with Order Donations 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 3Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 4Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 5
(Date:9/30/2014)... marijuana, new research, involving mice and published in the ... Leukocyte Biology , suggests that just because you ... because a team of Italian scientists have found that ... to the immune system. This damage may result in ... sclerosis, inflammatory bowel disease and rheumatoid arthritis in adulthood. ...
(Date:9/30/2014)... 2014  Spectra Automation, a trusted supplier ... and power generation industries, announced today the ... an easy-to-use and cost-effective data collection, analysis ... laboratories. Most upstream process ... systems. Accessing and consolidating data from these ...
(Date:9/29/2014)... the exposure to tar tended to be lower for ... Similarly, exposure to nicotine tended to be lower. , ... in several countries around the world. Previous studies have ... the smoke of these cigarettes are lower than those ... in the smoke are not necessarily linked to a ...
Breaking Biology News(10 mins):Adolescent exposure to thc may cause immune systems to go up in smoke 2Spectra Automation Introduces RECONN Bioprocess Manager 2Slim cigarette smokers not exposed to more harmful chemicals 2
Other Contents